Literature DB >> 8588201

Basal tissue factor expression in endothelial cell cultures is caused by contaminating smooth muscle cells. Reduction by using chymotrypsin instead of collagenase.

A B Mulder1, N R Blom, J W Smit, M H Ruiters, J van der Meer, M R Halie, V J Bom.   

Abstract

A discrepancy exists between basal tissue factor (TF) expression found in endothelial cell cultures and the failure to detect TF in unpertubated endothelial cells in vivo. We demonstrated that basal TF expression in endothelial cell cultures originated from contaminating cells. These cells were ultrastructurally and flowcytometrically identified as smooth muscle cells. The cell cultures had been obtained from collagenase-treated human umbilical cord vessels. Histologic studies revealed that after collagenase treatment the basement membrane was digested and underlying structures were disrupted at some areas of the vein. We selected chymotrypsin as an alternative for the isolation of endothelial cells. Using chymotrypsin, the endothelial lining was selectively lost leaving the basement membrane undisturbed. Furthermore, use of chymotrypsin instead of collagenase minimized the level of basal TF activity. Taken together, we demonstrated that basal TF expression in endothelial cell cultures is caused by contaminating smooth muscle cells. This contamination can strongly be reduced using chymotrypsin instead of collagenase for isolation of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588201     DOI: 10.1016/0049-3848(95)00192-t

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Cellular handling of a dexamethasone-anti-E-selectin immunoconjugate by activated endothelial cells: comparison with free dexamethasone.

Authors:  Robbert J Kok; Maaike Everts; Sigridur A Asgeirsdóttir; Dirk K F Meijer; Grietje Molema
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  A sensitive method for quantifying cytomegalic endothelial cells in peripheral blood from cytomegalovirus-infected patients.

Authors:  A M Kas-Deelen; M C Harmsen; E F de Maar; W J van Son; T H The
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

3.  Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?

Authors:  R H Brons; H I Bakker; R T Van Wijk; N W Van Dijk; A C Muller Kobold; P C Limburg; W L Manson; C G Kallenberg; J W Tervaert
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 4.  The influence of biomaterials on endothelial cell thrombogenicity.

Authors:  Alison P McGuigan; Michael V Sefton
Journal:  Biomaterials       Date:  2007-02-09       Impact factor: 12.479

5.  Porcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro.

Authors:  Zhengyu Pang; Laura E Niklason; George A Truskey
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

6.  Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.

Authors:  Zhiwei Hu; Benqiang Rao; Shimin Chen; Jinzhong Duanmu
Journal:  BMC Cancer       Date:  2010-05-26       Impact factor: 4.430

7.  Characterization of coagulation factor synthesis in nine human primary cell types.

Authors:  Monireh Dashty; Vishtaseb Akbarkhanzadeh; Clark J Zeebregts; C Arnold Spek; Eric J Sijbrands; Maikel P Peppelenbosch; Farhad Rezaee
Journal:  Sci Rep       Date:  2012-11-09       Impact factor: 4.379

8.  Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer.

Authors:  Zhiwei Hu; Jing Li
Journal:  BMC Immunol       Date:  2010-10-12       Impact factor: 3.615

9.  Polyacylurethanes as Novel Degradable Cell Carrier Materials for Tissue Engineering.

Authors:  Danijela Jovanovic; Frans V Roukes; Andrea Löber; Gerwin E Engels; Willem van Oeveren; Xavier J Gallego van Seijen; Marja J A van Luyn; Martin C Harmsen; Arend Jan Schouten
Journal:  Materials (Basel)       Date:  2011-10-06       Impact factor: 3.623

10.  RGD-avidin-biotin pretargeting to alpha v beta 3 integrin enhances the proapoptotic activity of TNF alpha related apoptosis inducing ligand (TRAIL).

Authors:  Marc Tarrus; Almer M van der Sloot; Kai Temming; Marie Lacombe; Frank Opdam; Wim J Quax; Grietje Molema; Klaas Poelstra; Robbert J Kok
Journal:  Apoptosis       Date:  2008-02       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.